Background: This study examined the association between different types of comorbidities and the quality of diabetes care, health-related quality of life (HRQoL), and total health care expenditure. Methods: Adult patients with diabetes were identified from the 2011 to 2013 Medical Expenditure Panel Survey, a nationally representative survey of the civilian non-institutionalized US population. Twenty different chronic conditions were captured and categorized as: (i) diabetes only; (ii) diabetes plus concordant (diabetes-related) comorbidity only; and (iii) diabetes plus one or more discordant (non-diabetes-related) comorbidities. Disease burden outcomes included the process of diabetes care (eye and foot examinations, HbA1c and cholesterol tests, influenza vaccination), HRQoL, and total health care expenditure. Multivariable models were used to examine associations between the type of comorbidity and outcomes. Results: A sample of 8292 patients with diabetes was identified, of which 11.4% had diabetes only, 40.5% had concordant comorbidity only, and 48.1% reported one or more discordant comorbidities. Patients with diabetes and either type of comorbidity received better quality of diabetes care than those without a comorbidity. However, patients with discordant comorbidity showed significantly lower HRQoL measures and higher health care expenditure than those with concordant comorbidity. Adjusted total mean annual expenditure was US$4891, $6326, and $9210 for those with diabetes only and those with diabetes with one concordant or one discordant comorbidity, respectively. Conclusions: Higher disease burden in patients with diabetes was associated with discordant rather than concordant comorbidity. Future interventional studies evaluating patient-centered care models addressing different types of comorbidity are necessary to better manage these complex patients.
Introduction
Diabetes is a chronic condition frequently associated with multiple comorbid conditions. 1 Previous studies reported that 50% of adult patients with diabetes have at least one comorbid condition, and approximately 40% of elderly patients with diabetes have four or more comorbid conditions. 2, 3 These comorbidities are likely to impair a patient's physical and mental health and prevent them from managing their disease states efficiently. [4] [5] [6] Diabetes self-care management or monitoring plans can be negatively affected in the presence of comorbidity. 7, 8 Economic burden is another barrier for appropriate diabetes and comorbidity management. 9 Patients with diabetes and comorbidity are likely to face difficulties choosing appropriate treatments for their primary disease state and comorbid conditions within their budget constraints. 10 To better understand the effect of comorbidity in patients with diabetes, Piette and Kerr 10 introduced a concept of concordant and discordant comorbidities associated with diabetes. "Concordant comorbidity" is defined as conditions that share similar components of the overall pathophysiologic risk profile and "are more likely to be the focus of the same disease and selfmanagement plan," such as hypertension and hyperlipidemia. 10 In general, similar care plans may be used to manage concordant comorbid conditions, which could lead to more effective diabetes care overall.
11 "Discordant comorbidities" are conditions whose treatments are not directly related to the pathogenesis or management plan for diabetes, and include arthritis and depression. 10 Discordant comorbidities do not share care plans with diabetes, and their treatment may even be opposite to that of diabetes care. Thus, patients with discordant comorbidity may be expected to receive a lower quality of care potentially due to time constraints and competing demands. 12 Currently little evidence exists regarding the effects of different types of comorbidity in patients with diabetes. Previous studies have focused on a single specific comorbidity (e.g. depression) 13, 14 rather than comorbidity as a whole. A few studies have performed holistic investigations of comorbidity, but have reported conflicting results. For example, Woodard et al. 15 reported that patients with both concordant and discordant comorbidity were more likely to receive overall good quality of diabetes care compared with patients without comorbidity. 15 However, Pentakota et al. reported poor quality of care among patients having discordant comorbidity compared with patients without comorbidity. 11 Other studies suggest that patients with diabetes and discordant comorbidity also have an increased risk for additional visit to general practitioners, 16 higher utilization of healthcare services, increased treatment costs, 17 and lower health-related quality of life (HRQoL) 18 than patients with only concordant conditions.
Understanding different types of comorbidity and their effects on the quality of care, as well as HROoL and economic outcomes is important. By investigating various outcomes, the present study aims to provide a comprehensive picture of the effects of different types of comorbidity and to guide future efforts to provide solutions for better care, improve HRQoL, and reduce health care costs in these patients. The aim of the present study was to examine the association between the type of comorbidity (i.e. discordant vs concordant comorbidity) on the burden of disease in patients with diabetes from a US nationally representative data sample.
Methods

Study design and data source
This study analyzed cross-sectional survey data from the Medical Expenditure Panel Survey (MEPS) Full Year Consolidated Data Files and Medical Condition Files from 2011 to 2013. The MEPS is a nationally representative survey of the civilian non-institutionalized population of all ages in the US. Conducted by the Agency for Healthcare Research and Quality, the MEPS collected data over five rounds of in-person interviews that covered a consecutive 2-year period. The MEPS collected data regarding all health care costs for all people for each medical event they experienced in the year, including the amount from each payment source. Expenditure in MEPS comprises direct payments for care provided during the year, including outof-pocket payments and payments by private insurance, Medicaid, Medicare, and other sources. 19 The study population of interest consists of adult patients with clinical classification codes of "049 (diabetes mellitus without complication)" or "050 (diabetes mellitus with complications)" for diabetes on the MEPS Medical Condition Files and without non-positive sampling weights.
The research was conducted in accordance with the tenets of the Declaration of Helsinki. The present study used MEPS data that are de-identified and publicly available; thus, individual consent was not obtained.
Definition of comorbid conditions
Twenty different chronic conditions suggested by the US Department of Health and Human Services 20 were captured to create three mutually exclusive study groups of interest. The concordant comorbidities include hypertension, hyperlipidemia, and congestive heart failure, whereas the discordant comorbidities include arthritis, osteoporosis, and asthma. The full list of chronic conditions is given in Table 1 .
The present study examined whether concordant and discordant comorbidities in patients with diabetes were associated with higher disease burden compared with having diabetes only; thus, three groups were created: (i) diabetes only; (ii) diabetes plus concordant comorbidity only; and (iii) diabetes plus one or more discordant comorbidities.
Study outcomes
The quality of diabetes care was assessed by selfreported receipt of one dilated eye examination, two or more HbA1c tests, one foot examination, one cholesterol test, and an influenza vaccination in the past year. Measures of HRQoL included the preference-based 6-Dimension Short Form Health Survey (SF-6D) 21 and physical component summary (PCS) and mental component summary (MCS) scores on the 12-Item ShortForm Health Survey (SF-12). 22 The primary economic outcomes were total direct annual health care expenditure, estimated in 2013 US dollars, which covered pharmacy, office visits, emergency department, inpatient, and residual costs. Residual costs included hospital outpatient, zero-night stay hospital use, home health care, dental care, vision aids, other medical equipment, and service-related costs.
Statistical analysis
Descriptive statistics were used to summarize patient demographic variables, socioeconomic status, and medication use. Differences between the comorbidity groups were compared using t-tests for continuous variables and the Rao-Scott Chi-squared test for categorical variables. The crude mean with 95% confidence intervals (CIs) was reported for each HRQoL and economic-related variable. Multivariable analysis was used to control for covariates including age, sex, race (non-Hispanic White, Hispanic, non-Hispanic Black, others), marital status, education (lower than high school, high school, college or more), perceived health (excellent/very good, good, fair/poor, unknown), region (Northeast, Midwest, South, West), insurance (uninsured, any private, public only [e.g. Medicare, Medicaid, TRICARE, or other public hospital or physician program]), poverty (poor/negative, near poor, low income, middle income, high income), and diabetes medication use (oral medication only, both insulin and oral, unknown/not applicable). Logistic regression models were used to estimate the effects of concordant and discordant comorbidity in patients with diabetes on the quality of diabetes care. Linear regression models were used to estimate the association of concordant and discordant comorbidity in patients with diabetes on HRQoL measures (SF-6D, SF-12 PCS, and SF-12 MCS scores). Generalized linear models with log-link and gamma distribution were used to estimate adjusted annual health care expenditure based on comorbidity type. Incremental costs and 95% CIs were estimated using a non-parametric cluster bootstrapping method. Subgroup analyses were conducted for individuals with only one additional comorbidity, two comorbidities, and three or more comorbidities. All analyses considered sampling strata and weights in this survey design.
Results
Baseline characteristics
A representative sample of 8292 adult patients with diabetes was identified from the MEPS data between 2011 and 2013 (Table 2) , of which approximately 11% reported diabetes only, 41% had concordant comorbidity only, and 48% reported diabetes with one or more discordant comorbidity. Only 4% of the study population had discordant comorbidity only, therefore most patients with one or more discordant comorbidity had both concordant and discordant comorbidity. A higher percentage of patients with discordant comorbidity reported fair or poor health status than those with concordant comorbidity only (63% vs 42%; P < 0.001). There were more patients with diabetes and discordant comorbidity who had public health insurance than patients with concordant comorbidity only (41% vs 30%; P < 0.001; Table 2 ). The most observed comorbidities in patients with diabetes and concordant comorbidity were hypertension (73%) and dyslipidemia (65%); for those with discordant comorbidity, the most common comorbidities were arthritis (20%) and depression (18%; Fig. 1 ).
Quality of diabetes care
Patients with concordant comorbidity and those with discordant comorbidity were more likely than those without comorbidity to receive a cholesterol test (odds those without comorbidity (Table 3) . However, patients with diabetes and either concordant or discordant comorbidity did not show any significant differences in quality of diabetes care measures (Table 3) .
Health-related quality of life
Adjusted mean (AESD) SF-6D, SF-12 PCS, and SF-12 MCS scores for diabetes only, diabetes with concordant comorbidity only, and diabetes with one or more discordant comorbidity are given in Table 3 . Compared with patients without comorbidity, those with discordant comorbidity had worse physical and mental status (significantly lower SF-6D, SF-12 PCS, and SF-12 MCS scores in patients with discordant comorbidity vs patients without comorbidity; all P < 0.001; Table 3 ).
In patients with diabetes and concordant comorbidity, SF-6D and SF-12 PCS scores showed significantly Prevalence of (a) concordant and (b) discordant comorbidity in diabetic patients. HTN, hypertension; Lipid, dyslipidemia; CAD, coronary artery disease; CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease. Health-related quality of life (HRQoL) outcomes are given as the mean AE SD. Data were adjusted for age, sex, race, marital status, education, region, insurance, poverty, duration of diabetes, and diabetes medication use. SF-6D, Short Form Health Survey -6 Dimensions; SF-12, Short Form Health Survey -12 Items; PCS, physical component summary; MCS, mental component summary.
worse health status compared with patients without comorbidity (P < 0.001; Table 3 ). Compared with patients with concordant comorbidity, HRQoL measures were significantly worse in patients with discordant comorbidity (P < 0.001; Table 3 ). Table 4 reports mean (95% CI) health care resource utilization and costs. The mean number of doctor office visits in patients with discordant comorbidity and concordant comorbidity was 14.0 (95% CI 13.1-14.9) and 8.4 (95% CI 7.7-9.1) respectively, whereas the mean number of prescription fills in patients with discordant comorbidity and concordant comorbidity was 51.4 (95% CI 49.1-53.6) and 33.5 (95% CI 31.8-35.1), respectively.
Health care resource utilization and costs
Total health care expenditure was higher for patients with diabetes and any type of comorbidity compared with patients with diabetes only (P = 0.006 for concordant comorbidity vs. diabetes only; P < 0.001 for discordant comorbidity vs. diabetes only). In addition, total health care expenditure was higher for patients with discordant comorbidity compared with those with concordant comorbidity only. The estimated mean differences in total health care expenditure between the study groups are presented in Table 5 . The estimated incremental health care expenditure of the group with diabetes plus discordant comorbidity relative to the group with diabetes plus concordant comorbidity was US$2815 (95% CI US$61-US$6653; P = 0.001) and US $1475 (95% CI US$128-US$2930; P = 0.028) for patients with one and two comorbidities, respectively (Table 5 ). However, the difference was no longer statistically significant in patients with three or more comorbidities (P = 0.520).
The estimated average total annual expenditure was US$4891 for those with diabetes only, US$6326 for those with diabetes and one concordant comorbidity, and US$9210 for those with diabetes and one discordant comorbidity (Fig. 2) . These higher expenditures were primarily driven by higher hospitalization and pharmacy costs (Fig. 2) .
Discussion
The results of the present study show that patients with diabetes and either a concordant or discordant comorbidity are more likely to receive diabetes preventative care than those without a comorbidity. There were similarities between the concordant and discordant comorbidity groups in terms of receiving regular diabetes check-up services recommended by the American Diabetes Association (ADA), 23 such as glycemic and lipid control and influenza vaccination. These findings are consistent with other published studies. For example, Woodard et al. confirmed higher achievement of diabetes care goals for glycemic and lipid control in patients with discordant comorbidity only compared with those with diabetes only. 15 Petrosyan et al. also showed that either type of comorbidity in patients was associated with meeting diabetes goals of HbA1c testing or lowdensity lipoprotein cholesterol testing. 16 These findings could be explained by the frequent interaction of patients with healthcare providers. In fact, in the present study, patients with comorbidity had almost double the number of physician office visits than those with diabetes only. With regard to HRQoL, patients with discordant comorbidity had significantly lower HRQoL measures in both physical and mental domains than patients in the other groups, whereas patients with concordant comorbidity reported lower physical health scores than those with diabetes only. Our findings are in line with those of O'Shea et al., who reported that the presence of one discordant comorbidity was associated with lower HRQoL compared with no comorbidity. 18 In addition, these findings suggest that patients with at least one discordant comorbidity have a poorer mental and physical health status than patients with concordant comorbidity only. Subgroup analyses by the number of comorbidities also confirmed that having different types of conditions (either concordant or discordant) affects a patient's health status regardless of the number of comorbidities.
The present study found that the health care expenditure of patients with one or more discordant comorbidity was higher than the expenditure of patients with a concordant comorbidity. Patients with discordant comorbidity are likely to have different treatment plans for diabetes and their comorbidity. In the present study, patients with discordant comorbidity had a higher number of office visits, emergency department admissions, and hospitalizations than those with concordant comorbidity. In addition, the duration of hospital stay for patients with a discordant comorbidity was longer, and they were likely to be prescribed more medications than patients with a concordant comorbidity. These findings are in line with those of Fisher et al., who reported that the main drivers of healthcare utilization were non-diabetes-related conditions. 24 Discordant comorbidity may have also caused an increased number of unplanned hospitalizations and specialized care utilization, which may have led to patients following treatment plans that compromised the potential to achieve diabetes care goals. 24 As a result of the higher utilization of healthcare services, discordant comorbidity was associated with higher expenditure for office visits, hospitalization, and prescription drug costs for the treatment of patients' conditions compared with concordant comorbidity. 24 Interestingly, the incremental health expenditure of diabetes patients with discordant comorbidity compared with diabetes patients with concordant comorbidity decreased as the number of comorbidities increased. The most important drivers of incremental health care expenditure in patients with discordant comorbidity are hospitalization, pharmacy, and office visit costs in patients with one additional comorbidity. When multiple different comorbidities exist (three or more), the differences between discordant and concordant comorbidity were no longer statistically significant, although overall health care expenditure increased. This pattern may be explained by efficiency in treating multiple conditions; some of the conditions may be managed by the same monitoring or treatment plans, therefore minimal additional costs are necessary. 24 These findings were also consistent for HRQoL outcomes. It is important to note that the present study selected 20 different chronic conditions suggested by the US Department of Health and Human Services 20 in their framework of multiple chronic conditions. This framework has been suggested due to the inconsistences of defining comorbidities across various studies. 20 Due to methodological differences in defining comorbidities, the results of the present study need to be interpreted with caution when comparing them with the results of other studies.
The results of the present study suggest that patients with diabetes and comorbidity, especially those with at least one discordant comorbidity, potentially require more intensive care management plans in order to prevent hospitalizations and to improve their HRQoL. Although these patients may meet the quality of diabetes care, healthcare providers should understand that the patients with discordant comorbidity experience lower HRQoL and have higher health care expenditure than others. These patients may also struggle with diabetes self-care, therefore continuous support from healthcare providers would be essential for patients with a comorbidity. In addition, access to care and care coordination in new patient-centered care models will benefit these individuals to reduce unnecessary office visits and further prevent hospitalizations or emergency department visits. 25, 26 Future studies evaluating new patient-centered care models or clinical programs Figure 2 Estimated adjusted mean healthcare expenditures by type of comorbidity. ER, emergency room.
among patients with discordant types of comorbidities are needed to improve patient outcomes.
Similar to other observational studies, the present study has several limitations due to its cross-sectional design using the MEPS survey data. The findings of this study should be interpreted as correlational rather than causal. In addition to following ADA recommendations, successful diabetes care management should be reflected by achieving a predetermined HbA1c measure. Because such laboratory values were not available in the MEPS data, the present study only investigated the process of quality of diabetes care (i.e. whether patients received recommended laboratory tests and medical examinations). Another limitation of the study was the inability to obtain reasons for hospitalizations and emergency visits, thus making it challenging to determine how different types of comorbidities affect patients' current diabetes management or management of comorbid conditions. Future studies may focus on causes of hospitalization and emergency visits for different types of comorbidities as well as diabetes-related long-term clinical outcomes. Moreover, the framework of concordant and discordant comorbidity may need to be applied differently for specific risk factors and outcomes; however, the present study followed the general framework suggested by Piette and Kerr. 10 For example, for influenza vaccination, chronic obstructive pulmonary disease, and diabetes are not necessarily discordant conditions because two diseases are likely to share the same management plan. Or patients with glaucoma and diabetes may be likely to receive eye examinations more often because the two conditions also share the same management plan. Future studies may be necessary to provide a more sophisticated concordant and discordant framework for different risk factors. In addition, the severity of diabetes was not measured, which may have affected the study outcome. Further, the results may have been different for type 1 and type 2 diabetes mellitus, but this was not addressed due to unavailability of data. Moreover, understanding a patient's perspective regarding their own health condition, such as prioritizing self-care under time constraints, lack of comprehensive knowledge, and financial burden, may also be beneficial. Finally, the quality of diabetes care or diabetes medication use was defined based on self-report. Potential recall bias, measurement errors, and missing data are limitations of the present study.
Despite these limitations, the present study has several strengths. The study used national representative survey data, thus the estimated prevalence of comorbid conditions in patients with diabetes likely reflects the national prevalence. In addition, all covariates and confounding factors were adjusted for accordingly using multivariable models; thus, any differences among study groups were confirmed with appropriate statistical tests. The survey followed the most current recommendations for diabetes care of the ADA when evaluating the quality of diabetes preventive care in populations with and without comorbidity. Moreover, this study investigated different types of comorbidity rather than individual comorbidity to provide a more comprehensive view of multiple chronic conditions that patients with diabetes may have. In addition, different aspects of comorbidity burden from the quality of diabetes care to total health care expenditure were investigated.
In conclusion, the present study showed an association of better quality of diabetes care in patients with diabetes and any type of comorbidity compared with diabetes only. In contrast, patients with diabetes and discordant comorbidity had a significantly lower HRQoL than those with diabetes only. In addition, patients with diabetes and discordant comorbidity incurred higher total health care expenditure than those with concordant comorbidity, with most costs driven by hospitalization and prescriptions. Future interventional studies evaluating patient-centered care models addressing different types of comorbidity are needed to better manage these complex patients.
